Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elizabeth E, Girroir"'
Autor:
Jeffrey M. Peters, Elizabeth E. Girroir, Bokai Zhu, Holly E. Hollingshead, Gary H. Perdew, Pengfei He
Publikováno v:
Biochemical and Biophysical Research Communications. 371:456-461
The expression patterns of PPARβ/δ have been described, but the majority of these data are based on mRNA data. To date, there are no reports that have quantitatively examined the expression of PPARβ/δ protein in mouse tissues. In the present stud
Autor:
Elizabeth E. Girroir, Timothy M. Willson, Frank J. Gonzalez, Michael G. Borland, Arun Sharma, Andrew N. Billin, Holly E. Hollingshead, Renee L. Killins, Shantu Amin, Jeffrey M. Peters
Publikováno v:
Carcinogenesis. 28:2641-2649
Ligands for peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) increase skeletal muscle fatty acid catabolism, improve insulin sensitivity, increase serum high-density lipoprotein cholesterol, elicit anti-inflammatory activity and
Autor:
Timothy M. Willson, Jeffrey M. Peters, Frank J. Gonzalez, Elizabeth E. Girroir, Andrew D. Burdick, Moses T. Bility, Andrew N. Billin
Publikováno v:
Cellular Signalling. 19:1163-1171
The functional role of peroxisome proliferator-activated receptor-beta(PPARbeta; also referred to as PPARdelta) in epidermal cell growth remains controversial. Recent evidence suggests that ligand activation of PPARbeta/delta increases cell growth an
Autor:
Elizabeth E, Girroir, Holly E, Hollingshead, Pengfei, He, Bokai, Zhu, Gary H, Perdew, Jeffrey M, Peters
Publikováno v:
Biochemical and biophysical research communications. 371(3)
The expression patterns of PPARbeta/delta have been described, but the majority of these data are based on mRNA data. To date, there are no reports that have quantitatively examined the expression of PPARbeta/delta protein in mouse tissues. In the pr
Autor:
Timothy M. Willson, Arun Sharma, Holly E. Hollingshead, Frank J. Gonzalez, Elizabeth E. Girroir, Shantu Amin, Gavin P. Robertson, Andrew N. Billin, Jeffrey M. Peters
The development of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands for the treatment of diseases including metabolic syndrome, diabetes and obesity has been hampered due to contradictory findings on their potential safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec2b9d88f65f073911485eb65dd86e5
https://europepmc.org/articles/PMC2278023/
https://europepmc.org/articles/PMC2278023/
Autor:
Holly E, Hollingshead, Renee L, Killins, Michael G, Borland, Elizabeth E, Girroir, Andrew N, Billin, Timothy M, Willson, Arun K, Sharma, Shantu, Amin, Frank J, Gonzalez, Jeffrey M, Peters
Publikováno v:
Carcinogenesis. 28(12)
Ligands for peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) increase skeletal muscle fatty acid catabolism, improve insulin sensitivity, increase serum high-density lipoprotein cholesterol, elicit anti-inflammatory activity and
Autor:
Holly E. Hollingshead, Renee L. Killins, Michael G. Borland, Elizabeth E. Girroir, Andrew N. Billin, Timothy M. Willson, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez, Jeffrey M. Peters
Publikováno v:
Carcinogenesis; Dec2007, Vol. 28 Issue 12, p2641-2641, 1p